I Donated My DNA to Help Stop the Coronavirus
By Ronnie S. Stangler,
Medium
| 04. 19. 2020
My personal calculus is that today, collective good trumps individual autonomy.
Last night, I entered intimate personal health information into a database that can be accessed by anyone. This is not a decision that I made lightly. I shared my information with the Personal Genome Project(PGP) at Harvard Medical School. Founded in 2005 by Dr. George Church, the PGP represents an ideal, a vision of effecting ultimate progress in DNA science through the generosity of participants willing to expose personal data for a greater good. Before Covid-19, the PGP used this data for open-source research projects to further our understanding of human genetics, biology, and health. The PGP will now singularly focus on Covid-19, studying both those who have the disease and those who don’t.
Their strategy is uniquely advantaged, as the PGP has already collected its participants’ DNA. Ideally, all subjects who have agreed to participate in this open-source project have already entered all varieties of medical information, from static measures of height, weight, and blood type to information collected over years through contacts with physicians and medical systems.
The grand scheme is to connect genotypes (obtained through...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...